GDNF and head and neck squamous cell carcinoma: However, positive stromal protein expression of GDNF may be associated with a higher risk of relapse in certain patients, especially those with HPV-negative HNSCC; therefore, systemic administration of GDNF for the goal of xerostomia treatment is not recommended.